Steve Schonfeld’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-13,700
Closed -$6.71K 2482
2023
Q2
$6.71K Buy
13,700
+300
+2% +$245 ﹤0.01% 1933
2023
Q1
$15.5K Sell
13,400
-12,100
-47% -$22.1K ﹤0.01% 1845
2022
Q4
$68.3K Sell
25,500
-46,300
-64% -$122K ﹤0.01% 2234
2022
Q3
$206K Buy
+71,800
New +$305K ﹤0.01% 2314
2021
Q4
Sell
-44,700
Closed -$874K 2670
2021
Q3
$874K Buy
+44,700
New +$1.7M 0.01% 1009
2021
Q2
Sell
-13,900
Closed -$699K 2429
2021
Q1
$699K Sell
13,900
-2,550
-16% -$174K 0.01% 1027
2020
Q4
$1.47M Buy
+16,450
New +$1.38M 0.02% 687

Other funds holding CELL

Steve Schonfeld's CELL Position: Q3 2023 in Review

Steve Schonfeld sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 13,700 shares — an estimated $6.71K sold.

Steve Schonfeld first reported a position in CELL in Q4 2020 and held it in 7 quarters. The position peaked at $1.47M in Q4 2020. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Steve Schonfeld reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Steve Schonfeld sold 13,700 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $6.71K.
  • Steve Schonfeld first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Steve Schonfeld's PhenomeX Inc. Common Stock position peaked at $1.47M in Q4 2020.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.